NCT03509597 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ojeda N, Peña J, Bengoetxea E, Garcia A, Sánchez P, Elizagárate E, Segarra R, Ezcurra J, Gutiérrez-Fraile M, Eguíluz JI
[Evidence of the effectiveness of cognitive rehabilitation in psychosis and schizophrenia with the REHACOP programme]. Rev Neurol. 201
Ojeda N, Peña J, Bengoetxea E, García A, Sánchez P, Elizagárate E, Segarra R, Ezcurra J, Gutiérrez-Fraile M, Eguíluz JI
[REHACOP: a cognitive rehabilitation programme in psychosis]. Rev Neurol. 2012 Mar 16;54(6):337-42. Spanish.
Ojeda N, Peña J, Sánchez P, Bengoetxea E, Elizagárate E, Ezcurra J, Gutiérrez Fraile M
Efficiency of cognitive rehabilitation with REHACOP in chronic treatment resistant Hispanic patients. NeuroRehabilitation. 2012;30(1):65-74. doi: 10.3233/NRE-2011-0728
Peña J, Ibarretxe-Bilbao N, Sánchez P, Iriarte MB, Elizagarate E, Garay MA, Gutiérrez M, Iribarren A, Ojeda N
Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial. NPJ
Peña J, Ibarretxe-Bilbao N, Sánchez P, Uriarte JJ, Elizagarate E, Gutierrez M, Ojeda N
Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J Psychiatr Res. 2018 Jun;101:21-27. doi: 10.1016/j.jpsychires.2018.03.002. Epu
Sánchez P, Peña J, Bengoetxea E, Ojeda N, Elizagárate E, Ezcurra J, Gutiérrez M
Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: a randomized controlled trial. Schizophr Bull. 2014 May;40(3):7

A Randomized, Open-Label, Parallel-Group Study to Investigate The Effect of Cognitive Training and Aerobic Exercise on Brain, Functional Outcome and Cognition in Schizophrenia

Details for clinical trial NCT03509597

Clinical trial NCT03509597 - References